The Mechanism and Dynamic Regulation of Epithelial to Mesenchymal Transition in Ovarian Cancer

被引:4
|
作者
Prayudi, Pande Kadek Aditya [1 ,2 ]
Winata, I. Gde Sastra [1 ,2 ]
Mahendra, Nyoman Bayu [1 ,2 ]
Budiana, I. Nyoman Gede [1 ,2 ]
Saspriyana, Kade Yudi [1 ,2 ]
Suwiyoga, Ketut [1 ,2 ]
机构
[1] Prof Dr I GNG Ngoerah Hosp, Dept Obstet & Gynecol, Div Gynecol Oncol, Denpasar 80113, Bali, Indonesia
[2] Udayana Univ, Fac Med, Denpasar 80113, Bali, Indonesia
来源
关键词
ovarian cancer; epithelial-to-mesenchymal transition; cellular reprogramming; PROMOTES VASCULOGENIC MIMICRY; HEDGEHOG SIGNALING PATHWAY; E-CADHERIN; CELL-MIGRATION; STEM-CELLS; TRANSCRIPTION FACTORS; CISPLATIN-RESISTANCE; POOR SURVIVAL; LNCRNA-ATB; EMT;
D O I
10.31083/j.ceog5012272
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To understand the basic mechanism and dynamic regulation that underlies the epithelial-to-mesenchymal transition (EMT) in ovarian cancer (OC) cells. Mechanism: A literature review using evidences from several data bases (i.e., PubMed, EMBASE, Web of Science, Medline, Cochrane, Science Direct, and Google Scholar) were conducted to describe the basic mechanism and dynamic regulation of EMT in OC cells. Finding in Brief: EMT is a complex epigenetic reprogramming orchestrated by specific transcription factors (TFs) and multiple upstream activators and regulators, such as transforming growth factor-0 (TGF-0), Wnt, Hedgehog, and Hippo signaling pathways. The net result of this cellular reprogramming is the acquisition of mesenchymal phenotypes with increased invasive and metastatic potential, stemness properties and chemoresistance. Recent studies have demonstrated that EMT activation is the result of dynamic and reciprocal interplay between OC cells and their tumor microenvironment (TME). Cellular or non-cellular component of TME, external factors related to TME such as hypoxia, oxidative stress, mechanical forces, as well as exposure to chemotherapy, all play significant role to EMT induction. Current understanding behind the mechanism of EMT induction in cancer cells have proposed the idea that EMT is not merely a binary process involving a complete conversion from epithelial to mesenchymal state, but rather a dynamic process that encompasses a range of hybrid states, a phenotype that has been referred to as "partial EMT". Cells with partial EMT have been known to be more apoptosis-resistant and have more tumor-initiating potential as compared to those with complete EMT. Conclusions: Understanding the complex regulatory network that underlies EMT in OC cells is crucial in order to gain insight in developing novel and effective treatment strategies for OC.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] RASAL2 down-regulation in ovarian cancer promotes epithelial-mesenchymal transition and metastasis
    Huang, Yuting
    Zhao, Meng
    Xu, Haixu
    Wang, Ke
    Fu, Zheng
    Jiang, Yuan
    Yao, Zhi
    ONCOTARGET, 2014, 5 (16) : 6734 - 6745
  • [22] MicroRNA Regulation of Epithelial to Mesenchymal Transition
    Abba, Mohammed L.
    Patil, Nitin
    Leupold, Joerg Hendrik
    Allgayer, Heike
    JOURNAL OF CLINICAL MEDICINE, 2016, 5 (01)
  • [23] Epigenetic regulation of epithelial–mesenchymal transition
    Lidong Sun
    Jia Fang
    Cellular and Molecular Life Sciences, 2016, 73 : 4493 - 4515
  • [24] Regulation of the Epithelial to Mesenchymal Transition in Osteosarcoma
    Hinton, Kristin
    Kirk, Andrew
    Paul, Paulose
    Persad, Sujata
    BIOMOLECULES, 2023, 13 (02)
  • [25] EPITHELIAL TO MESENCHYMAL TRANSITION Layers of regulation
    Seton-Rogers, Sarah
    NATURE REVIEWS CANCER, 2011, 11 (10) : 688 - 688
  • [26] Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer
    Deng, Junli
    Wang, Li
    Chen, Hongmin
    Hao, Jingli
    Ni, Jie
    Chang, Lei
    Duan, Wei
    Graham, Peter
    Li, Yong
    ONCOTARGET, 2016, 7 (34) : 55771 - 55788
  • [27] Nigericin inhibits epithelial ovarian cancer metastasis by suppressing the cell cycle and epithelial−mesenchymal transition
    Wen Wang
    Yan Zhao
    Shujuan Yao
    Xiujuan Cui
    Wenying Pan
    Wenqian Huang
    Jiangang Gao
    Taotao Dong
    Shiqian Zhang
    Biochemistry (Moscow), 2017, 82 : 933 - 941
  • [28] Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk
    Amankwah, Ernest K.
    Lin, Hui-Yi
    Tyrer, Jonathan P.
    Lawrenson, Kate
    Dennis, Joe
    Chornokur, Ganna
    Aben, Katja K. H.
    Anton-Culver, Hoda
    Antonenkova, Natalia
    Bruinsma, Fiona
    Bandera, Elisa V.
    Bean, Yukie T.
    Beckmann, Matthias W.
    Bisogna, Maria
    Bjorge, Line
    Bogdanova, Natalia
    Brinton, Louise A.
    Brooks-Wilson, Angela
    Bunker, Clareann H.
    Butzow, Ralf
    Campbell, Ian G.
    Carty, Karen
    Chen, Zhihua
    Chen, Y. Ann
    Chang-Claude, Jenny
    Cook, Linda S.
    Cramer, Daniel W.
    Cunningham, Julie M.
    Cybulski, Cezary
    Dansonka-Mieszkowska, Agnieszka
    Du Bois, Andreas
    Despierre, Evelyn
    Dicks, Ed
    Doherty, Jennifer A.
    Doerk, Thilo
    Duerst, Matthias
    Easton, Douglas F.
    Eccles, Diana M.
    Edwards, Robert P.
    Ekici, Arif B.
    Fasching, Peter A.
    Fridley, Brooke L.
    Gao, Yu-Tang
    Gentry-Maharaj, Aleksandra
    Giles, Graham G.
    Glasspool, Rosalind
    Goodman, Marc T.
    Gronwald, Jacek
    Harrington, Patricia
    Harter, Philipp
    GENETIC EPIDEMIOLOGY, 2015, 39 (08) : 689 - 697
  • [29] Actin Cytoskeleton Regulation of Epithelial Mesenchymal Transition in Metastatic Cancer Cells
    Shankar, Jay
    Nabi, Ivan R.
    PLOS ONE, 2015, 10 (03):
  • [30] Thrombin promotes epithelial ovarian cancer cell invasion by inducing epithelial-mesenchymal transition
    Zhong, Yi-Cun
    Zhang, Ting
    Di, Wen
    Li, Wei-Ping
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2013, 24 (03) : 265 - 272